IN House rejects marijuana amendment; Study: Cannabis classification not aligned with science; Op-Ed: CBD patients need more than fed hemp ban delay
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen.
- Cole Preston of ColeMemo.com: “I support Marijuana Moment because consistent, factual reporting on drug policy is essential—especially as laws change faster than public understanding. Their work helps keep policymakers, advocates and the public grounded in what’s actually happening.”
If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
U.S. Department of Agriculture scientists published a study that the agency says “redefined the value of roots in industrial hemp, providing new opportunities for industrial hemp growers and opening new avenues for pediatric cancer research.”
The Indiana House of Representatives rejected an amendment that would have allowed farmers to begin cultivating marijuana seed with new special use permits—which the sponsor said would help the state “get prepared” for federal cannabis rescheduling.
A new scientific review concludes that “U.S. drug policy does not align with experts’ rankings of drug harms”—finding, for example, that “cannabis was rated as less harmful than its Schedule I status suggests.”
Realm of Caring Executive Director Sasha Kalcheff-Korn argues in a new Marijuana Moment op-ed that for hemp farmers and patients who rely on CBD, delaying the federal recriminalization of hemp products is “just a band-aid” and that “regulatory certainty” is needed.
The Missouri Division of Cannabis Regulation revised guidance to attempt to clarify whether medical marijuana patients can buy from licensed dispensaries as adult-use consumers—though purchase limit rules complicate the situation.
/ FEDERAL
White House Office of National Drug Control Policy Director Sara Carter Bailey said officials are seeing fentanyl “laced in vapes and marijuana.”
Sen. Ted Budd (R-NC) tweeted, “Rescheduling marijuana to a Schedule III substance will put more money in the pockets of marijuana companies & will have detrimental effects on the health and safety of Americans, especially our nation’s youth.”
Sen. Susan Collins (R-ME) said in a press release about the Senate Judiciary Committee’s approval of President Donald Trump’s nominee for U.S. attorney for Maine that she’s concerned about “illegal Chinese marijuana grow houses” in her state.
/ STATES
The Maine legislature’s Veterans and Legal Affairs Committee is considering a bill to legalize marijuana consumption lounges.
The Ohio legislature’s Ibogaine Treatment Study Committee will meet on Wednesday.
A Florida judge issued a split ruling on state officials’ decision to toss signatures for a proposed marijuana legalization ballot initiative.
A spokesperson for a Massachusetts campaign seeking to roll back marijuana legalization with a proposed ballot initiative addressed accusations of fraudulent petitioning tactics.
The organizer of an Arizona campaign behind a proposed ballot initiative to recriminalize recreational marijuana sales discussed the measure.
Michigan regulators published a report on the hemp program.
Pennsylvania’s medical cannabis program has seen a decline in patient enrollment over the past year.
California regulators are launching a compliance education effort on kratom and 7-OH products ahead of enforcement actions.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ LOCAL
Niles Township. Michigan officials are being sued over a local ban on marijuana businesses.
The Boston, Massachusetts Cannabis Board will meet on Wednesday.
/ INTERNATIONAL
Victoria, British Columbia, Canada’s police chief said he doesn’t expect to see a spike in drug arrests when the province’s decriminalization trial is concluded at the end of this month.
German lawmakers are considering scaling back some proposed restrictive changes to medical cannabis policies.
/ SCIENCE & HEALTH
A study highlighted “the potential of CBD as an adjunctive therapeutic agent for cancer treatment versus non-malignant cells.”
A study found that “longer sitting times are associated with a lower likelihood of marijuana use among U.S. adults.”
A study found that “acute migraine treatment with 6% THC + 11% CBD was superior to placebo at 2-h post-treatment with sustained benefits at 24 and 48 h.”
/ ADVOCACY, OPINION & ANALYSIS
The New York Post editorial board criticized Gov. Kathy Hochul’s (D) plan to create a Center for Excellence for Cannabis Care and Health Equity.
/ BUSINESS
Colorado retailers sold $108.2 million worth of legal marijuana products in October.
/ CULTURE
A shuttered marijuana business co-owned by Ice-T is facing a lawsuit over allegedly unpaid bills.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Photo courtesy of Chris Wallis // Side Pocket Images.
Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
